Fitzgerald Health Education Associates

April 2015

Fitzgerald Health Education Associates (FHEA) is committed to the success of nurse practitioners; we publish practical information for practicing NPs and NP students, which includes NP interviews, NP certification Q&A;, avoiding malpractice, and news.

Issue link: https://fhea.epubxp.com/i/505458

Contents of this Issue

Navigation

Page 25 of 27

25 Fitzgerald Health Education Associates, Inc., April 2015 fhea.com References 1. Express Scripts. A nation in pain. Focusing on U.S. opioid trends for treatment of short-term and longer-term pain . De- c ember 9, 2014. Available at http://lab.express-scripts.com/publica- tions/a-nation-in-pain 2. Thomas K. Patients prescribed narcotic painkillers use more of them for longer, study finds. New York Times . December 9, 2014. FDA Panel Recommends New Safety Warnings for Two Diabetes Meds Most members of an FDA advisory panel voted to recommend that two dipeptidyl peptidase-4 in- hibitors (DPP-4s), saxagliptin (Onglyza) and alogliptin (Nesina), have label updates that include information about new safety issues that have recently become known from results of two cardiovascular outcomes studies first presented at the European Society of Cardiology meeting in 2013 and later published in the New England Journal of Medicine. The panelists voted to update the saxagliptin la- beling, primarily on the increased risk for heart fail- ure; the group also wanted to see data on the trend toward higher all-cause mortality. There was a 27% increase in the rate of the first event of hospitaliza- tion for heart failure and a potential increased risk for all-cause mortality, the panel members said. The committee members also voted to update the labeling of alogliptin with new data about heart fail- ure, which they were concerned could potentially be a class-wide problem. One panel member noted that although there are issues with both saxagliptin and alogliptin, clinicians should not come away with the idea that there are huge problems with these medications; rather, they should understand that there are things to be care- ful about when prescribing. • Word to the Wise Up-to-date Fitzgerald Health Education Associates products are available only at FHEA.COM ! To avoid any confusion or difficulty, purchase from FHEA. By doing so, you will: • Be eligible for CE credit • Have access to online materials or testing • Receive up-to-date, complete materials and editions Shop at FHEA.COM to ensure that you receive authentic FHEA products! FHEA stands behind our products and strives to ensure NP satisfaction. NP Certification Tracks In accordance with the recent implementation of the Consensus Model for APRN Regulation, FHEA is offering the following NP Certification Exam Review and Advanced Practice Update courses for all related exams: • Family Primary Care • Adult-Gerontology Primary Care • Adult Primary Care • Adult-Gerontology Acute Care • Psychiatric & Mental Health Family and Adult • Pediatric Primary Care • Women's Health Click here for more information Fitzgerald Health Education Associates, Inc. News Briefs C ontinued from page 23

Articles in this issue

Links on this page

Archives of this issue

view archives of Fitzgerald Health Education Associates - April 2015